Clinical Trial Update: A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating JNJ-66525433 in healthy participants and in patients with Ulcerative Colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• JNJ-66525433

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Healthy, Colitis, Ulcerative | Phase 1 | Status: TERMINATED